| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.22 | 6e-06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.078 | 0.1 |